Alliancebernstein L.P. Merck & Co., Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 11,186,762 shares of MRK stock, worth $1.38 Billion. This represents 0.54% of its overall portfolio holdings.

Number of Shares

11,186,762

Previous 8,997,337 24.33%

Holding current value

$1.38 Billion

Previous $981 Million 50.49%

% of portfolio

0.54%

Previous 0.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $248 Million - $289 Million	2,189,425 Added 24.33%	11,186,762 $1.48 Billion
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $39.3 Million - $42.7 Million	-392,115 Reduced 4.18%	8,997,337 $981 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $11 Million - $12.2 Million	-106,397 Reduced 1.12%	9,389,452 $967 Million
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $54.2 Million - $59.1 Million	-499,387 Reduced 5.0%	9,495,849 $1.1 Billion
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $120 Million - $134 Million	1,168,389 Added 13.24%	9,995,236 $1.06 Billion

Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $123 Million - $158 Million	1,408,442 Added 18.99%	8,826,847 $979 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $6.64 Million - $7.46 Million	78,595 Added 1.07%	7,418,405 $639 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $61.5 Million - $69.7 Million	736,222 Added 11.15%	7,339,810 $669 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $6.59 Million - $7.39 Million	-89,633 Reduced 1.34%	6,603,588 $542 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $24.2 Million - $30.3 Million	334,299 Added 5.26%	6,693,221 $513 Million
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $47.4 Million - $52.1 Million	-661,227 Reduced 9.42%	6,358,922 $478 Million
Q2 2021 Jul 30, 2021	SELL	$70.31 - $77.77 $31.9 Million - $35.3 Million	-453,733 Reduced 6.07%	7,020,149 $546 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $13.6 Million - $16 Million	-197,133 Reduced 2.57%	7,473,882 $576 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $127 Million - $141 Million	-1,775,017 Reduced 18.79%	7,671,015 $627 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $159 Million - $180 Million	-2,171,224 Reduced 18.69%	9,446,032 $784 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $3.23 Million - $3.68 Million	-45,875 Reduced 0.39%	11,617,256 $898 Million
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $29.7 Million - $41.2 Million	-468,940 Reduced 3.87%	11,663,131 $897 Million
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $93.4 Million - $105 Million	1,204,495 Added 11.02%	12,132,071 $1.1 Billion
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $47 Million - $51.3 Million	-618,276 Reduced 5.35%	10,927,576 $920 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $1.7 Million - $1.98 Million	24,278 Added 0.21%	11,545,852 $968 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $15.4 Million - $17.5 Million	220,867 Added 1.95%	11,521,574 $958 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $89.1 Million - $103 Million	1,366,185 Added 13.75%	11,300,707 $863 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $166 Million - $195 Million	2,873,511 Added 40.7%	9,934,522 $705 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $105 Million - $124 Million	-2,072,009 Reduced 22.69%	7,061,011 $429 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $69.5 Million - $80.8 Million	1,364,526 Added 17.56%	9,133,020 $497 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $10 Million - $12 Million	-194,070 Reduced 2.44%	7,768,494 $437 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $467 Million - $503 Million	7,962,564	7,962,564 $510 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Merck & Co., Inc. Transaction History